Literature DB >> 7201958

Isoflavone content of soya-based laboratory animal diets.

P A Murphy, E Farmakalidis, L D Johnson.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1982        PMID： 7201958     DOI： 10.1016/s0278-6915(82)80299-8

Source DB:  PubMed          Journal:  Food Chem Toxicol        ISSN： 0278-6915            Impact factor:   6.023


× No keyword cloud information.
  6 in total

1.  Variation in commercial rodent diets induces disparate molecular and physiological changes in the mouse uterus.

Authors:  Haibin Wang; Susanne Tranguch; Huirong Xie; Gregory Hanley; Sanjoy K Das; Sudhansu K Dey
Journal:  Proc Natl Acad Sci U S A       Date:  2005-06-29       Impact factor: 11.205

2.  Inhibitory effects of O-methylated isoflavone glycitein on human breast cancer SKBR-3 cells.

Authors:  Bo Zhang; Jun-Ping Su; Yang Bai; Jie Li; Yong-Hong Liu
Journal:  Int J Clin Exp Pathol       Date:  2015-07-01

3.  Chemical reaction of soybean flavonoids with DNA: a computational study using the implicit solvent model.

Authors:  Hassan H Abdallah; Janez Mavri; Matej Repič; Vannajan Sanghiran Lee; Habibah A Wahab
Journal:  Int J Mol Sci       Date:  2012-01-25       Impact factor: 6.208

4.  Soy isoflavone glycitein protects against beta amyloid-induced toxicity and oxidative stress in transgenic Caenorhabditis elegans.

Authors:  Astrid Gutierrez-Zepeda; Ross Santell; Zhixin Wu; Marishka Brown; YanJue Wu; Ikhlas Khan; Christopher D Link; Baolu Zhao; Yuan Luo
Journal:  BMC Neurosci       Date:  2005-08-25       Impact factor: 3.288

Review 5.  A case of a laboratory animal feed with high estrogenic activity and its impact on in vivo responses to exogenously administered estrogens.

Authors:  H Boettger-Tong; L Murthy; C Chiappetta; J L Kirkland; B Goodwin; H Adlercreutz; G M Stancel; S Mäkelä
Journal:  Environ Health Perspect       Date:  1998-07       Impact factor: 9.031

6.  Selective Estrogen Receptor β Agonists: a Therapeutic Approach for HIV-1 Associated Neurocognitive Disorders.

Authors:  Kristen A McLaurin; Landhing M Moran; Rosemarie M Booze; Charles F Mactutus
Journal:  J Neuroimmune Pharmacol       Date:  2019-12-19       Impact factor: 4.147
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.